DE69108242D1 - Antikoagulanszubereitung. - Google Patents

Antikoagulanszubereitung.

Info

Publication number
DE69108242D1
DE69108242D1 DE69108242T DE69108242T DE69108242D1 DE 69108242 D1 DE69108242 D1 DE 69108242D1 DE 69108242 T DE69108242 T DE 69108242T DE 69108242 T DE69108242 T DE 69108242T DE 69108242 D1 DE69108242 D1 DE 69108242D1
Authority
DE
Germany
Prior art keywords
antikoagulans
preparation
epi
increase
mucopolysaccharide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69108242T
Other languages
English (en)
Other versions
DE69108242T2 (de
Inventor
Ole Nordfang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Publication of DE69108242D1 publication Critical patent/DE69108242D1/de
Application granted granted Critical
Publication of DE69108242T2 publication Critical patent/DE69108242T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Separation Of Suspended Particles By Flocculating Agents (AREA)
  • Materials For Medical Uses (AREA)
DE69108242T 1990-06-19 1991-05-30 Antikoagulanszubereitung. Expired - Fee Related DE69108242T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK148890A DK148890D0 (da) 1990-06-19 1990-06-19 Farmaceutisk praeparat
PCT/DK1991/000145 WO1991019514A1 (en) 1990-06-19 1991-05-30 An anticoagulant preparation

Publications (2)

Publication Number Publication Date
DE69108242D1 true DE69108242D1 (de) 1995-04-20
DE69108242T2 DE69108242T2 (de) 1995-07-06

Family

ID=8105367

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69108242T Expired - Fee Related DE69108242T2 (de) 1990-06-19 1991-05-30 Antikoagulanszubereitung.

Country Status (11)

Country Link
EP (1) EP0535129B1 (de)
JP (1) JP3362038B2 (de)
AT (1) ATE119781T1 (de)
AU (1) AU645581B2 (de)
BG (1) BG61181B1 (de)
CA (1) CA2085101A1 (de)
DE (1) DE69108242T2 (de)
DK (2) DK148890D0 (de)
ES (1) ES2069894T3 (de)
HU (1) HU221323B1 (de)
WO (1) WO1991019514A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6291427B1 (en) 1990-08-27 2001-09-18 G.D. Searle & Co. Anticoagulant combination of LACI and sulfated polysaccharides
US5849703A (en) * 1990-08-27 1998-12-15 G. D. Searle & Co. Pre-formed anticoagulant heparin/TFPI complexes
DK261490D0 (da) * 1990-10-31 1990-10-31 Novo Nordisk As New pharmaceutical compound
US5276015A (en) * 1992-03-18 1994-01-04 Washington University Method of inhibiting microvascular thrombosis
US6063764A (en) * 1992-06-01 2000-05-16 Washington University & Chiron Corp. Method for using lipoprotein associated coagulation inhibitor to treat sepsis
US20030171292A1 (en) 1992-06-01 2003-09-11 Creasey Abla A. Method for using lipoprotein associated coagulation inhibitor to treat sepsis
AU4408493A (en) * 1992-06-11 1994-01-04 Washington University Prophylaxis and treatment of sepsis and sepsis-associated coagulation disorders
ZA941414B (en) * 1993-03-02 1994-09-28 Novo Nordisk A G Non-glycosylated TFPI analogues
US5981471A (en) * 1997-02-06 1999-11-09 Entremed, Inc. Compositions and methods for inhibiting cellular proliferation
IL161408A0 (en) 2001-10-15 2004-09-27 Chiron Corp Treatment of sepsis by low dose administration of tissue factor pathway inhibitor (tfpi)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE12779T1 (de) * 1980-09-30 1985-05-15 Bayer Ag Verfahren zur herstellung eines antithrombinheparin-komplexes sowie diesen komplex enthaltende pharmazeutische mischungen.
US4689323A (en) * 1983-09-26 1987-08-25 Miles Laboratories, Inc. Covalently bound heparin--antithrombin-III complex
IL79255A0 (en) * 1986-06-26 1986-09-30 Hadassah Med Org Composition for metastasis prevention
US4900723A (en) * 1988-04-29 1990-02-13 E. R. Squibb & Sons, Inc. Method of preventing or reducing venous thrombosis using a thromboxane A2 receptor antagonist in conjunction with heparin and combination
DK408089D0 (da) * 1989-08-18 1989-08-18 Novo Nordisk As Proteiner

Also Published As

Publication number Publication date
JP3362038B2 (ja) 2003-01-07
HUT63578A (en) 1993-09-28
AU8060491A (en) 1992-01-07
AU645581B2 (en) 1994-01-20
ATE119781T1 (de) 1995-04-15
EP0535129B1 (de) 1995-03-15
BG61181B1 (bg) 1997-02-28
JPH05507926A (ja) 1993-11-11
DK0535129T3 (da) 1995-08-07
ES2069894T3 (es) 1995-05-16
DK148890D0 (da) 1990-06-19
DE69108242T2 (de) 1995-07-06
HU221323B1 (en) 2002-09-28
HU9204036D0 (en) 1993-03-29
CA2085101A1 (en) 1991-12-20
WO1991019514A1 (en) 1991-12-26
EP0535129A1 (de) 1993-04-07

Similar Documents

Publication Publication Date Title
BG60253B1 (bg) Човешки тъканен плазминогенен активатор
FI931097A0 (fi) Laekemedel, deras framstaellning och anvaendning vid bekaempning av smaertor och/eller inflammationen hos maenniskor och djur
ES2119411T5 (es) Combinaciones de proteinas y anticoagulantes tromboliticamente activos, y usos de los mismos.
DE69108242D1 (de) Antikoagulanszubereitung.
HU9301253D0 (en) Medical preparative applicable for treatment of enlarged time of coagulation
EA200400548A1 (ru) Лечение тяжёлой пневмонии путём введения ингибитора пути тканевого фактора (tfpi)
TR200002078T2 (tr) Sentetik polisakkaridler, hazırlanmaları için proses ve bunları içeren farmasötik kompozisyonlar.
DK0910428T3 (da) Fotoferesebehandling af kroniske HCV-infektioner
ATE311191T1 (de) Apoptotische körper zur verwendung in der behandlung von t-zell-vermittelten- und entzündungserkrankungen
ES2055314T3 (es) Tratamiento de disfuncion leucocitaria con gm-csf.
DK0651654T3 (da) Anvendelse af lysozymdimer til fremstilling af et lægemiddel til styrkelse af de naturlige forsvarsmekanismer
ATE458495T1 (de) Therapeutische zubereitung für autoimmune erkrankungen
DK225689A (da) Anvendelse af metalloporphyriner til modvirkning af den toksiske virkning af tumorterapi
EP0340933A3 (de) Heparin enthaltende Formulierungen
RU92016457A (ru) Антикоагулирующий препарат
DE69128465D1 (de) Heparinneutralisierung durch blutplättchenfaktor
DK0788355T3 (da) Anvendelse af intravenøst indgiveligt jern til behandling af tumorsygdomme og/eller infektionssygdomme
ES293856U (es) Articulo ortopedico mejorado
UA30723A (uk) Спосіб лікування аутоімунних захворювань

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee